Vitamin D Level and its Relation with the Newly Diagnosed Diabetic Neuropathy in Women with Hypothyroidism

Document Type : Original Articles

Authors

Department of Chemistry, College of Education for Pure Science, Ibn-Al-Haitham University, Baghdad, Iraq

Abstract

Diabetic nephropathy has an important role in the kidneys’ function to remove extra fluid and waste products from the body. One way to avoid this disease is the treatment of other diseases, such as diabetes, thyroid gland diseases, and high blood pressure, in addition to maintaining a healthy lifestyle. This study aimed to find the relationship of thyroid hormone, blood biochemical parameters, and anthropometric measurement with the newly diagnosed diabetic neuropathy in women with hypothyroidism. In total, 90 women (with an age range of 35-55 years) were selected, 45 of whom were diagnosed with diabetic neuropathy and had hypothyroidism, and the other 45 were healthy women recruited as the control group. The following parameters were determined: serum triiodothyronine, thyroxine, thyroid stimulating hormone (TSH), 1,25-Dihydroxyvitamin D3 (DHVD3) activities, anthropometric measurement, fasting blood sugar (FBS), hemoglobin A1C (HbA1C), urea, creatinine, and lipid profile. The results showed a significant increase in the body mass index, blood pressure, TSH, FSB, HbA1C, urea, creatinine, and triglycerides of women with newly diagnosed diabetic neuropathy and hypothyroidism, compared to that in the control group (P≤0.05). A significant decrease was also observed in the high-density lipoprotein cholesterol, DHVD3, total triiodothyronine, and total thyroxine of women with newly diagnosed diabetic neuropathy and hypothyroidism, compared to that in the control group (P≤0.05). There was a correlation between vitamin D3 deficiency (VDD) and thyroid dysfunction in women with the newly diagnosed diabetic neuropathy, which indicated VDD is related to thyroid dysfunction and influences newly diagnosed diabetic neuropathy in women.

Keywords


  1. Alicic RZ, Rooney MT, Tuttle KR. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032-45.
  2. Ritz E, Zeng XX, Rychlik I. Clinical manifestation and natural history of diabetic nephropathy. Contrib Nephrol. 2011;170:19-27.
  3. Doshi SM, Friedman AN. Diagnosis and Management of Type 2 Diabetic Kidney Disease. Clin J Am Soc Nephrol. 2017;12(8):1366-73.
  4. Pugliese G. Updating the natural history of diabetic nephropathy. Acta Diabetol. 2014;51(6):905-15.
  5. Kordonouri O, Maguire AM, Knip M, Schober E, Lorini R, Holl RW, et al. Other complications and associated conditions with diabetes in children and adolescents. Pediatr Diabetes. 2009;10 (12):204-10.
  6. Barker JM, Yu J, Yu L, Wang J, Miao D, Bao F, et al. Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care. 2005;28(4):850-5.
  7. Baxter JD, Webb P. Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat Rev Drug Discov. 2009;8(4):308-20.
  8. Diekman T, Lansberg PJ, Kastelein JJ, Wiersinga WM. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Intern Med. 1995;155(14):1490-5.
  9. Tokinaga K, Oeda T, Suzuki Y, Matsushima Y. HMG-CoA reductase inhibitors (statins) might cause high elevations of creatine phosphokinase (CK) in patients with unnoticed hypothyroidism. Endocr J. 2006;53(3):401-5.
  10. Song SH, Kwak IS, Lee DW, Kang YH, Seong EY, Park JS. The prevalence of low triiodothyronine according to the stage of chronic kidney disease in subjects with a normal thyroid-stimulating hormone. Nephrol Dial Transplant. 2009;24(5):1534-8.
  11. Van Belle TL, Gysemans C, Mathieu C. Vitamin D in autoimmune, infectious and allergic diseases: a vital player? Best Pract Res Clin Endocrinol Metab. 2011;25(4):617-32.
  12. Van Belle TL, Gysemans C, Mathieu C. Vitamin D and diabetes: the odd couple. Trends Endocrinol Metab. 2013;24(11):561-8.
  13. Tamer G, Arik S, Tamer I, Coksert D. Relative vitamin D insufficiency in Hashimoto's thyroiditis. Thyroid. 2011;21(8):891-6.
  14. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5.
  15. Papazafiropoulou A, Sotiropoulos A, Kokolaki A, Kardara M, Stamataki P, Pappas S. Prevalence of thyroid dysfunction among greek type 2 diabetic patients attending an outpatient clinic. J Clin Med Res. 2010;2(2):75-8.
  16. Kim D. Low vitamin D status is associated with hypothyroid Hashimoto's thyroiditis. Hormones. 2016;15(3):385-93.
  17. Bozkurt NC, Karbek B, Ucan B, Sahin M, Cakal E, Ozbek M, et al. The association between severity of vitamin D deficiency and Hashimoto's thyroiditis. Endocr Pract. 2013;19(3):479-84.
  18. Chailurkit LO, Aekplakorn W, Ongphiphadhanakul B. High vitamin D status in younger individuals is associated with low circulating thyrotropin. Thyroid. 2013;23(1):25-30.
  19. Wanner C, Krane V, Marz W, Olschewski M, Asmus HG, Kramer W, et al. Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics. Kidney Blood Press Res. 2004;27(4):259-66.
  20. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353(3):238-48.
  21. Franczyk-Skora B, Gluba A, Banach M, Kozlowski D, Malyszko J, Rysz J. Prevention of sudden cardiac death in patients with chronic kidney disease. BMC Nephrol. 2012;13:162.
  22. Kaptein EM, Wilcox RB, Nelson JC. Assessing thyroid hormone status in a patient with thyroid disease and renal failure: from theory to practice. Thyroid. 2004;14(5):397-400.
  23. Meuwese CL, Dekker FW, Lindholm B, Qureshi AR, Heimburger O, Barany P, et al. Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2012;7(1):131-8.
  24. Crowley WF, Jr., Ridgway EC, Bough EW, Francis GS, Daniels GH, Kourides IA, et al. Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med. 1977;296(1):1-6.
  25. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501-9.
  26. Schmid C, Brandle M, Zwimpfer C, Zapf J, Wiesli P. Effect of thyroxine replacement on creatinine, insulin-like growth factor 1, acid-labile subunit, and vascular endothelial growth factor. Clin Chem. 2004;50(1):228-31.
  27. McDonough AA, Brown TA, Horowitz B, Chiu R, Schlotterbeck J, Bowen J, et al. Thyroid hormone coordinately regulates Na+-K+-ATPase alpha- and beta-subunit mRNA levels in kidney. Am J Physiol. 1988;254(2 Pt 1):C323-9.
  28. Wheatley T, Edwards OM. Mild hypothyroidism and oedema: evidence for increased capillary permeability to protein. Clin Endocrinol. 1983;18(6):627-35.
  29. Bener A, Al-Hamaq AO, Kurtulus EM, Abdullatef WK, Zirie M. The role of vitamin D, obesity and physical exercise in regulation of glycemia in Type 2 Diabetes Mellitus patients. Diabetes Metab Syndr. 2016;10(4):198-204.
  1. Bener A, Ozdenkaya Y, Al-Hamaq A, Barisik CC, Ozturk M. Low Vitamin D Deficiency Associated With Thyroid Disease Among Type 2 Diabetic Mellitus Patients. J Clin Med Res. 2018;10(9):707-14.
  2. Welsh KJ, Soldin SJ. DIAGNOSIS OF ENDOCRINE DISEASE: How reliable are free thyroid and total T3 hormone assays? Eur J Endocrinol. 2016;175(6):R255-R63.
  3. Akbar DH, Ahmed MM, Al-Mughales J. Thyroid dysfunction and thyroid autoimmunity in Saudi type 2 diabetics. Acta Diabetol. 2006;43(1):14-8.
  4. Palma CC, Pavesi M, Nogueira VG, Clemente EL, Vasconcellos Mde F, Pereira LCJ, et al. Prevalence of thyroid dysfunction in patients with diabetes mellitus. Diabetol Metab Syndr. 2013;5(1):58.
  5. Toulis K, Tsekmekidou X, Potolidis E, Didangelos T, Gotzamani-Psarrakou A, Zebekakis P, et al. Thyroid Autoimmunity in the Context of Type 2 Diabetes Mellitus: Implications for Vitamin D. Int J Endocrinol. 2015;2015:710363.